Medical diagnostics company CareDx Inc on Tuesday filed a lawsuit accusing larger rival Natera Inc of using patented organ transplantation technology without authorization.
CareDx’s lawsuit, filed in federal court in Delaware, alleged Natera’s recently announced test for determining the success of a kidney transplant surgery infringed on two patents.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2CA2U8D
Our Standards: The Thomson Reuters Trust Principles.